HCAT
Income statement / Annual
Last year (2023), Health Catalyst, Inc.'s total revenue was $295.94 M,
an increase of 7.13% from the previous year.
In 2023, Health Catalyst, Inc.'s net income was -$118.15 M.
See Health Catalyst, Inc.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
| Operating Revenue |
$295.94 M
|
$276.24 M
|
$241.93 M
|
$188.85 M
|
$154.94 M
|
$112.57 M
|
$73.08 M
|
| Cost of Revenue |
$164.11 M |
$143.05 M |
$124.35 M |
$98.08 M |
$75.35 M |
$59.85 M |
$43.64 M |
| Gross Profit |
$131.83 M |
$133.19 M |
$117.57 M |
$90.77 M |
$79.60 M |
$52.72 M |
$29.44 M |
| Gross Profit Ratio |
0.45 |
0.48 |
0.49 |
0.48 |
0.51 |
0.47 |
0.4 |
| Research and Development
Expenses |
$72.63 M
|
$75.68 M
|
$62.73 M
|
$53.52 M
|
$46.25 M
|
$38.59 M
|
$28.47 M
|
| General & Administrative
Expenses |
$76.56 M
|
$61.70 M
|
$85.93 M
|
$59.24 M
|
$31.71 M
|
$22.69 M
|
$14.70 M
|
| Selling & Marketing
Expenses |
$67.32 M
|
$87.51 M
|
$75.03 M
|
$55.41 M
|
$47.28 M
|
$44.12 M
|
$25.92 M
|
| Selling, General &
Administrative Expenses |
$143.88 M
|
$149.22 M
|
$160.96 M
|
$114.65 M
|
$79.00 M
|
$66.81 M
|
$40.62 M
|
| Other Expenses |
$42.22 M |
$48.30 M |
$37.53 M |
$18.73 M |
$9.21 M |
-$39,000.00 |
-$4,000.00 |
| Operating Expenses |
$258.73 M |
$273.19 M |
$261.22 M |
$186.89 M |
$134.46 M |
$112.82 M |
$74.98 M |
| Cost And Expenses |
$422.84 M |
$416.24 M |
$385.58 M |
$284.97 M |
$209.81 M |
$172.67 M |
$118.62 M |
| Interest Income |
$16.39 M |
$5.69 M |
$831,000.00 |
$2.09 M |
$2.81 M |
$602,000.00 |
$542,000.00 |
| Interest Expense |
$7.29 M |
$1.68 M |
$16.46 M |
$11.57 M |
$3.42 M |
$2.59 M |
$1.47 M |
| Depreciation &
Amortization |
$45.21 M
|
$51.53 M
|
$41.11 M
|
$23.03 M
|
$9.21 M
|
$7.41 M
|
$5.89 M
|
| EBITDA |
-$66.46 M
|
-$82.92 M
|
-$101.68 M
|
-$79.47 M
|
-$44.48 M
|
-$52.12 M
|
-$39.75 M
|
| EBITDA Ratio |
-0.22 |
-0.33 |
-0.44 |
-0.41 |
-0.29 |
-0.46 |
-0.54 |
| Operating Income Ratio
|
-0.43
|
-0.51
|
-0.59
|
-0.51
|
-0.35
|
-0.53
|
-0.62
|
| Total Other
Income/Expenses Net |
$9.11 M
|
-$1.68 M
|
-$16.46 M
|
-$20.09 M
|
-$5.09 M
|
-$2.02 M
|
-$1.47 M
|
| Income Before Tax |
-$117.79 M |
-$141.68 M |
-$160.11 M |
-$116.21 M |
-$59.95 M |
-$62.12 M |
-$47.01 M |
| Income Before Tax Ratio
|
-0.4
|
-0.51
|
-0.66
|
-0.62
|
-0.39
|
-0.55
|
-0.64
|
| Income Tax Expense |
$356,000.00 |
-$4.28 M |
-$6.90 M |
-$1.19 M |
$142,000.00 |
-$135,000.00 |
$26,000.00 |
| Net Income |
-$118.15 M |
-$137.40 M |
-$153.21 M |
-$115.02 M |
-$60.10 M |
-$61.98 M |
-$47.04 M |
| Net Income Ratio |
-0.4 |
-0.5 |
-0.63 |
-0.61 |
-0.39 |
-0.55 |
-0.64 |
| EPS |
-2.09 |
-2.56 |
-3.23 |
-2.91 |
-3.21 |
-2.23 |
-1.69 |
| EPS Diluted |
-2.09 |
-2.54 |
-3.23 |
-2.91 |
-3.21 |
-2.23 |
-1.69 |
| Weighted Average Shares
Out |
$56.42 M
|
$53.72 M
|
$47.49 M
|
$39.54 M
|
$18.74 M
|
$27.77 M
|
$27.77 M
|
| Weighted Average Shares
Out Diluted |
$56.42 M
|
$54.08 M
|
$47.49 M
|
$39.54 M
|
$18.74 M
|
$27.77 M
|
$27.77 M
|
| Link |
|
|
|
|
|
|
|
